Clinical Trials Logo

Filter by:
  • Recruiting  
  • « Prev · Page [2]
NCT ID: NCT02762851 Recruiting - Heart Failure Clinical Trials

Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)

RCT-IVVE
Start date: June 2016
Phase: Phase 4
Study type: Interventional

A multi-centre, randomized, placebo controlled, trial. Participants at high-risk for vascular events from the network of INTER- CHF will be randomized to inactivated influenza vaccine or placebo and followed prospectively over three influenza seasons. 5,000 participants will be enrolled prior to influenza season, randomized to either influenza vaccine or saline placebo, either of which they will receive annually for three years and then followed over each of the influenza seasons.

NCT ID: NCT01805232 Recruiting - Malaria Clinical Trials

Intravenous Artesunate and Malaria

IVAS
Start date: March 2013
Phase: Phase 4
Study type: Interventional

Intravenous artesunate is egual to quinine in the treatment of severe malaria

NCT ID: NCT01713517 Recruiting - Malaria, Falciparum Clinical Trials

Impact of Insecticide Resistance on Vector Control

Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether long lasting insecticidal nets and indoor residual insecticide spraying, alone or in combination, are effective for controlling insecticide resistant anopheles mosquitoes for malaria prevention.

NCT ID: NCT01319734 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus

Vit C
Start date: February 2011
Phase: Phase 1
Study type: Interventional

Null hypothesis: No significant effect of vitamin C 500 mg Supplementation on the severity of micro-vascular complications of type 2 Diabetes Mellitus (DM). Alternative hypothesis: There is a significant effect of vitamin C 500mg supplementation on the severity of the micro-vascular complications of type 2DM.